Article Figures & Data
Tables
UK (n = 72) RT (n = 125) Age (mean ± SD), yr 58 ± 15 61 ± 13 Male 36 (50.0) 67 (53.6) Female 36 (50.0) 58 (46.4) Hypertension 43 (59.7) 78 (62.4) Diabetes mellitus 14 (19.4) 20 (16.0) Coronary artery disease 13 (18.0) 33 (26.4) Atrial fibrillation 14 (19.4) 29 (23.2) Tobacco use 11 (15.3) 26 (20.8) Blood glucose (mean ± SD), mg/dl 149.4 ± 55 134.0 ± 51 Presentation NIHSS median (range) 16 (3–27) 18 (2–39) Prior IV rtPA treatment (n = 182) 65 (90.3) 117 (93.6) -
Note:—Values in parentheses are percentages, except for Presentation NIHSS median.
-
UK (n = 72) RT (n = 125) ICA occlusion 22 (30.5) 50 (40.0) Carotid-t occlusion 8 (11.0) 23 (18.4) MCA occlusion 50 (69.5) 75 (60.0) M1 occlusion 32 (44.5) 45 (36.0) M2 occlusion 18 (25.0) 30 (24.0) IA thrombolytic dose (median, range) 200,000 U (25,000–1,500,000 U) 2 mg (1–8 mg) Mechanical thrombolysis 43 (59.7) 90 (72.0) Clot disruption with microwire 18 37 Snare 2 3 Balloon 3 7 Balloon +stent 5 6 Merci 13 30 Penumbra 0 3 Merci + Penumbra 0 3 Merci + balloon + stent 2 1 -
Note:—Values in parentheses are percentages, except for IA thrombolytic dose.
-
UK (n = 72) RT (n = 125) P Value Δ NIHSS in 24 hr (mean ± SD) 3.2 ± 7.8 2.0 ± 6.8 .32 Final TICI ≥2b 40 (55.5) 77 (61.6) .45 Discharge mRS, 0–3 27 (37.5) 49 (39.2) .87 SICH 3 (4.2) 10 (8.0) .29 Death 11 (15.3) 20 (16.0) .89 -
Note:—Values in parentheses are percentages.
-
UK (n = 72) RT (n = 125) P Value ICA occlusions Final TICI ≥2b 13 (59.1) 32 (64.0) .86 Discharge mRS, 0–3 5 (22.7) 12 (24) .98 M1 occlusions Final TICI ≥2b 16 (50.0) 28 (62.2) .23 Discharge mRS, 0–3 12 (37.5) 21 (46.6) .37 M2 occlusions Final TICI ≥2b 10 (55.5) 16 (53.3) .85 Discharge mRS, 0–3 10 (55.5) 13 (43.3) .46 -
Note:—Values in parentheses are percentages.
-